Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of intravenous treosulfan in secondary progressive and progressive relapsing multiple sclerosis
2006-002856-14Phase 2Terminated
- Sponsor
- medac GmbH
- Start
- Nov 2006
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of treosulfan in secondary-progressive multiple sclerosis (SPMS) and multiple sclerosis (MS) (3 arms), sponsored by medac GmbH. Started Nov 2006; status: terminated.
02
Drugs
treosulfan
03
Conditions
secondary-progressive multiple sclerosis (SPMS)multiple sclerosis (MS)
Beyond the preview
Go deeper on 2006-002856-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002856-14.